COVID‐19 vaccination in pediatric solid organ transplant recipients—Current state and future directions

COVID‐19 vaccination in pediatric solid organ transplant recipients—Current state and future directions

Background Population‐level COVID‐19 immunization will play a key role in slowing down the SARS‐CoV‐2 pandemic on a global scale and protect the most at‐risk individuals. Thanks to a formidable universal effort, several SARS‐CoV‐2 vaccines have been marketed less than a year since the first document...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric transplantation 2021-09, Vol.25 (6), p.e14031-n/a
Hauptverfasser: L’Huillier, Arnaud G., Ardura, Monica I., Chaudhuri, Abanti, Danziger‐Isakov, Lara, Dulek, Daniel, Green, Michael, Michaels, Marian G., Posfay‐Barbe, Klara M., Vàsquez, Luciola, Benden, Christian
Format: Artikel
Sprache:eng
Schlagworte:
Children
Clinical trials
COVID-19
COVID-19 vaccines
Immunization
Immunogenicity
Pandemics
Pediatrics
Personal Viewpoint
Safety
SARS‐CoV‐2
Severe acute respiratory syndrome coronavirus 2
solid organ transplantation
Transplantation
Transplants & implants
vaccine
Vaccines
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Population‐level COVID‐19 immunization will play a key role in slowing down the SARS‐CoV‐2 pandemic on a global scale and protect the most at‐risk individuals. Thanks to a formidable universal effort, several SARS‐CoV‐2 vaccines have been marketed less than a year since the first documented COVID‐19 case, with promising safety, efficacy, and immunogenicity results in adults. As children were not included in the initial trials, no vaccine is currently approved for individuals
ISSN:1397-3142
1399-3046
DOI:10.1111/petr.14031